The impact of RhoA and Rac1 on glioma migration is in good agreement with the observation of an increased FAK activation, negatively regulating RhoA and activating Rac1 in glioma, being associated with staging and a poorer prognosis [504,515]. This evidence concerns the gene PTK2 and glioma.